About 3D BioFibR

3D BioFibR produces collagen fibers using patented dry-spinning technology, enabling the commercial-scale manufacturing of materials that mimic the biomechanical and biochemical properties of natural collagen. These fibers are designed for tissue engineering applications, including 3D bioprinting additives and cellular scaffolds, addressing the need for reliable and scalable biomaterials in regenerative medicine.

```xml <problem> Current methods of producing collagen fibers for tissue engineering struggle to replicate the complex biomechanical and biochemical properties of natural collagen, hindering the development of effective regenerative medicine solutions. Existing manufacturing processes often lack the scalability needed to meet the growing demand for reliable biomaterials in applications like 3D bioprinting and cell culturing. </problem> <solution> 3D BioFibR utilizes a patented dry-spinning technology to produce CollaFibR™, collagen fibers that closely mimic the structure and function of native collagen. Their automated manufacturing system enables the commercial-scale production of these fibers, addressing the limitations of traditional methods. CollaFibR™ serves as a versatile biomaterial for tissue engineering, enhancing the performance of 3D bioprinting additives, hydrogels, and cellular scaffolds used in both 2D and 3D cell and tissue cultures. The technology provides researchers and manufacturers with a consistent and scalable source of high-quality collagen fibers. </solution> <features> - Patented dry-spinning technology for collagen fiber production - Automated manufacturing system enabling commercial-scale production - CollaFibR™ fibers that mimic the biomechanical and biochemical properties of natural collagen - Suitable for use as additives in 3D bioprinting - Compatible with hydrogels for improved tissue engineering applications - Effective as cellular scaffolds for 2D and 3D cell and tissue culture </features> <target_audience> The primary target audience includes researchers and manufacturers in the fields of tissue engineering, regenerative medicine, 3D bioprinting, and cell culture. </target_audience> ```

What does 3D BioFibR do?

Where is 3D BioFibR located?

3D BioFibR is based in Halifax, Canada.

When was 3D BioFibR founded?

3D BioFibR was founded in 2020.

How much funding has 3D BioFibR raised?

3D BioFibR has raised 3600000.

Location

Halifax, Canada

Founded

2020

Funding

3600000

Employees

16 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

3D BioFibR

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

3dbiofibr.com 2K+

Founded 2020 – Halifax, Canada

Funding

Estimated Funding

$3M+

Team (15+)

No team information available.

Company Description

Problem

Current methods of producing collagen fibers for tissue engineering struggle to replicate the complex biomechanical and biochemical properties of natural collagen, hindering the development of effective regenerative medicine solutions. Existing manufacturing processes often lack the scalability needed to meet the growing demand for reliable biomaterials in applications like 3D bioprinting and cell culturing.

Solution

3D BioFibR utilizes a patented dry-spinning technology to produce CollaFibR™, collagen fibers that closely mimic the structure and function of native collagen. Their automated manufacturing system enables the commercial-scale production of these fibers, addressing the limitations of traditional methods. CollaFibR™ serves as a versatile biomaterial for tissue engineering, enhancing the performance of 3D bioprinting additives, hydrogels, and cellular scaffolds used in both 2D and 3D cell and tissue cultures. The technology provides researchers and manufacturers with a consistent and scalable source of high-quality collagen fibers.

Features

Patented dry-spinning technology for collagen fiber production

Automated manufacturing system enabling commercial-scale production

CollaFibR™ fibers that mimic the biomechanical and biochemical properties of natural collagen

Suitable for use as additives in 3D bioprinting

Compatible with hydrogels for improved tissue engineering applications

Effective as cellular scaffolds for 2D and 3D cell and tissue culture

Target Audience

The primary target audience includes researchers and manufacturers in the fields of tissue engineering, regenerative medicine, 3D bioprinting, and cell culture.